APM (APM)
Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
Live quote temporarily unavailable — press releases and news are still shown below.
No company overview is available for APM yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
APM has not issued a press release in this window.
SEC filings
All filings →APM has not filed an SEC document in this window.
Insider trades
All insider trades →APM has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
CITADEL ADVISORS LLC$122,519
115,584 sh● NEW
TWO SIGMA INVESTMENTS, LP$18,456
17,411 sh● NEW
MORGAN STANLEY$14,098
13,300 sh● NEW
5,501 sh0.0%
UBS Group AG$2,382
2,247 sh● NEW
400 sh● NEW
7 sh0.0%
People at APM
All people →No officers or directors have been indexed for APM.
Quarterly financials
Full financials →Revenue trend
12/24
$431.4K
NI -$4.3M
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.